Related Experiment Video
Updated: Aug 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
The problem of hypertension in the elderly
1Department of Clinical Pharmacology, Sahlgrenska University Hospital, Göteborg, Sweden. thomas.hedner@pharm.gu.se
Insights
Elderly hypertension management is crucial due to population aging. Newer blood pressure medications, like ACE inhibitors, are as effective as older ones in reducing cardiovascular risks in older adults.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Aging populations globally are experiencing a rise in hypertension prevalence.
- Hypertension in the elderly significantly contributes to cardiovascular disease (CVD) mortality and morbidity.
- Aggressive hypertension management is warranted due to proven benefits of antihypertensive treatment in reducing CVD events.
Purpose of the Study:
- To evaluate the efficacy of newer antihypertensive agents compared to older ones in elderly patients.
- To assess the impact of different antihypertensive drug classes on cardiovascular mortality and morbidity in the elderly population.
Main Methods:
- The study analyzed data from the second Swedish Trial in Old Patients with Hypertension (STOP-Hypertension-2).
- It compared the effectiveness of angiotensin converting enzyme (ACE) inhibitors and calcium antagonists against older antihypertensive agents.
Main Results:
- Newer agents, including ACE inhibitors and calcium antagonists, demonstrated equivalent efficacy to older treatments.
- Both newer and older antihypertensive medications significantly reduced cardiovascular mortality and morbidity in elderly participants.
Conclusions:
- Newer antihypertensive medications are a safe and effective option for managing hypertension in the elderly.
- The findings support the use of ACE inhibitors and calcium antagonists for reducing cardiovascular risks in older adults with hypertension.
Abstract:
Since most developed countries have an ageing population, the prevalence of hypertension is increasing. This age-driven increase in cardiovascular risk is an important factor contributing to the increasing burden of mortality and morbidity associated with cardiovascular disease. Today, there is a strong rationale for an aggressive approach to hypertension since antihypertensive treatment has been shown to reduce cardiovascular mortality and morbidity in the elderly. It is likely that increasing emphasis will be placed on control of isolated and borderline systolic hypertension, which are the predominant forms of hypertension in elderly patients. The recent second Swedish Trial in Old Patients with Hypertension (STOP-Hypertension-2) represents an important contribution to the literature since it shows that newer antihypertensive agents, such as angiotensin converting enzyme (ACE) inhibitors and calcium antagonists, are as effective as older agents in reducing cardiovascular mortality and morbidity in elderly patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management

